Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Guang Fan
Affiliation
Oregon Health and Science University
ORCID
Career Start Year
2000
Papers
59
H Index
17
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37199721
Patient-Specific Targeting of the T-Cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases.
Clin Cancer Res
2023
37685882
Cytogenetically Cryptic Acute Promyelocytic Leukemia: A Diagnostic Challenge.
Int J Mol Sci
2023
34482403
Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML.
Blood
2022
37552730
Community-Based SARS-CoV-2 Testing Using Saliva or Nasopharyngeal Swabs to Compare the Performance of Weekly COVID-19 Screening to Wastewater SARS-CoV-2 Signals.
ACS ES T Water
2022
35802949
A novel heptasomy 21 associated with complete loss of heterozygosity and loss of function RUNX1 mutation in acute myeloid leukemia.
Cancer Genet
2022
35380701
T-cell Dysfunction upon Expression of MYC with Altered Phosphorylation at Threonine 58 and Serine 62.
Mol Cancer Res
2022
35885487
Myelodysplastic Syndrome: Diagnosis and Screening.
Diagnostics (Basel)
2022
35884893
PD-1/PD-L1 Pathway: A Therapeutic Target in CD30+ Large Cell Lymphomas.
Biomedicines
2022
36008543
Bimodal distribution pattern associated with the PCR cycle threshold (Ct) and implications in COVID-19 infections.
Sci Rep
2022
35258401
Adult acute myeloid leukemia patients with <i>NUP98</i> rearrangement have frequent cryptic translocations and unfavorable outcome.
Leuk Lymphoma
2022
35254096
Using Spike Gene Target Failure to Estimate Growth Rate of the Alpha and Omicron Variants of SARS-CoV-2.
J Clin Microbiol
2022
33089525
A novel somatic PLCG2 variant associated with resistance to BTK and SYK inhibition in chronic lymphocytic leukemia.
Eur J Haematol
2021
33901720
Engrafted Donor-Derived Clonal Hematopoiesis after Allogenic Hematopoietic Cell Transplantation is Associated with Chronic Graft-versus-Host Disease Requiring Immunosuppressive Therapy, but no Adverse Impact on Overall Survival or Relapse.
Transplant Cell Ther
2021
33870648
Clinical applications of monitoring immune status with 90 immune cell subsets in human whole blood by 10-color flow cytometry.
Int J Lab Hematol
2021
34559205
In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported.
Blood Adv
2021
34611480
NEDD8-activating enzyme inhibition induces cell cycle arrest and anaphase catastrophe in malignant T-cells.
Oncotarget
2021
34431689
Comparison of SARS-CoV-2 PCR-Based Detection Using Saliva or Nasopharyngeal Swab Specimens in Asymptomatic Populations.
Microbiol Spectr
2021
32126021
<i>GAA</i> compound heterozygous mutations associated with autophagic impairment cause cerebral infarction in Pompe disease.
Aging (Albany NY)
2020
35846098
Biclonal plasma cell leukemia associated with a complex karyotype, TP53 deletion, and high-risk disease.
EJHaem
2020
31866570
Molecular Discordance between Myeloid Sarcomas and Concurrent Bone Marrows Occurs in Actionable Genes and Is Associated with Worse Overall Survival.
J Mol Diagn
2020
32242922
Mast cell sarcoma with concurrent mast cell leukaemia.
Br J Haematol
2020
32513686
Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia.
Proc Natl Acad Sci U S A
2020
31145495
The combination of NPM1, DNMT3A, and IDH1/2 mutations leads to inferior overall survival in AML.
Am J Hematol
2019
31754026
Differentiation of leukemic blasts is not completely blocked in acute myeloid leukemia.
Proc Natl Acad Sci U S A
2019
31738840
Primary cutaneous Epstein-Barr virus-positive diffuse large B-cell lymphoma (DLBCL) in a patient taking fingolimod.
Dermatol Online J
2019
31124175
Next-generation sequencing-defined minimal residual disease before stem cell transplantation predicts acute myeloid leukemia relapse.
Am J Hematol
2019
28868942
MYC immunohistochemical and cytogenetic analysis are required for identification of clinically relevant aggressive B cell lymphoma subtypes.
Leuk Lymphoma
2018
30052721
Trends in Bone Marrow Sampling and Core Biopsy Specimen Adequacy in the United States and Canada: A Multicenter Study.
Am J Clin Pathol
2018
28990859
Hematoxylin Bodies in Pediatric Bone Marrow Aspirates and their Utility in the Diagnosis of Systemic Lupus Erythematosus.
Pediatr Dev Pathol
2018
29199519
Outcomes of DA-EPOCH-R induction plus autologous transplant consolidation for double hit lymphoma.
Leuk Lymphoma
2018
29165010
DNMT3A co-mutation is required for FLT3-ITD as an adverse prognostic indicator in intermediate-risk cytogenetic group AML.
Leuk Lymphoma
2018
27761930
Concurrent STAT3, DNMT3A, and TET2 mutations in T-LGL leukemia with molecularly distinct clonal hematopoiesis of indeterminate potential.
Am J Hematol
2017
27124934
Targeted Next-Generation Sequencing in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia Aids Diagnosis in Challenging Cases and Identifies Frequent Spliceosome Mutations in Transformed Acute Myeloid Leukemia.
Am J Clin Pathol
2016
26119982
The Corepressor Rcor1 Is Essential for Normal Myeloerythroid Lineage Differentiation.
Stem Cells
2015
26231802
MYD88 mutation analysis of a rare composite chronic lymphocyte leukemia and lymphoplasmacytic lymphoma by flow cytometry cell sorting.
Ann Hematol
2015
24652990
Corepressor Rcor1 is essential for murine erythropoiesis.
Blood
2014
25125625
Aberrations of MYC are a common event in B-cell prolymphocytic leukemia.
Am J Clin Pathol
2014
24637335
Functional integration of acute myeloid leukemia into the vascular niche.
Leukemia
2014
23087056
Kinase pathway dependence in primary human leukemias determined by rapid inhibitor screening.
Cancer Res
2013
24319570
Diffuse large B-cell lymphoma in adults aged 75 years and older: a single institution analysis of cause-specific survival and prognostic factors.
Ther Adv Hematol
2013
23836506
Mutations in γ adducin are associated with inherited cerebral palsy.
Ann Neurol
2013
23278912
Early precursor T-lymphoblastic leukaemia/lymphoma arising from paediatric chronic myeloid leukaemia - unusual lymph node blast crisis.
Br J Haematol
2013
22035377
RAS mutations in therapy-related acute myeloid leukemia after successful treatment of acute promyelocytic leukemia.
Leuk Lymphoma
2012
22658276
Multiplex high-throughput gene mutation analysis in acute myeloid leukemia.
Hum Pathol
2012
22425895
Newly described activating JAK3 mutations in T-cell acute lymphoblastic leukemia.
Leukemia
2012
21502425
Association of JAK2 mutation status and cytogenetic abnormalities in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms.
Am J Clin Pathol
2011
19801969
Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms.
Mod Pathol
2010
20959657
Immunophenotypic correlation between skin biopsy and peripheral blood findings in mycosis fungoides.
Am J Clin Pathol
2010
20551277
Immunophenotypic variations of Burkitt lymphoma.
Am J Clin Pathol
2010
18237230
A unique case of adolescent CD56-negative extranodal NK/T-cell lymphoma, nasal type.
Pediatr Dev Pathol
2008
1 - 50 of 59
Column Actions
Search
Recommended Authors
Xiaoqiong Wang
The University of Texas MD Anderson Cancer Center
Career Start Year
2011
Number of shared co-authors
0
David Wu
University of Washington
Career Start Year
2010
Number of shared co-authors
3
Alexa J Siddon
Yale School of Medicine
Career Start Year
2010
Number of shared co-authors
0
Bartlomiej Przychodzen
Vanda Pharmaceuticals Inc.
Career Start Year
2010
Number of shared co-authors
1
Anagha Deshpande
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year
2009
Number of shared co-authors
0
Alexandra E Kovach
Children's Hospital of Los Angeles
Career Start Year
2008
Number of shared co-authors
3
Paulo Vidal Campregher
Hospital Israelita Albert Einstein
Career Start Year
2007
Number of shared co-authors
1
Rashmi Kanagal-Shamanna
The University of Texas MD Anderson Cancer Center
Career Start Year
2006
Number of shared co-authors
3
Jean-Baptiste Micol
INSERM U7, Universite Paris-Saclay
Career Start Year
2004
Number of shared co-authors
0
Melissa H Cessna
Intermountain Medical Center
Career Start Year
2001
Number of shared co-authors
0
Jeffery M Klco
St. Jude Children's Research Hospital
Career Start Year
2000
Number of shared co-authors
3
Sze Fai Yip
Tuen Mun Hospital
Career Start Year
1999
Number of shared co-authors
0
Lukas D Wartman
Washington University School of Medicine in St. Louis
Career Start Year
1998
Number of shared co-authors
1
Francisco Vega
The University of Texas MD Anderson Cancer Center
Career Start Year
1996
Number of shared co-authors
3
Yongjin Li
Mayo Clinic
Career Start Year
1995
Number of shared co-authors
4
Jean Soulier
University of Paris
Career Start Year
1993
Number of shared co-authors
3
Seishi Ogawa
Kyoto University
Career Start Year
1993
Number of shared co-authors
3
Arndt Borkhardt
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Career Start Year
1992
Number of shared co-authors
1
Christopher D Gocke
Johns Hopkins University School of Medicine
Career Start Year
1992
Number of shared co-authors
2
Claude Preudhomme
Lille University Hospital, INSERM UMR-S7, CNRS UMR9020, Lille University.
Career Start Year
1989
Number of shared co-authors
0
Mark J Routbort
University of Texas MD Anderson Cancer Center
Career Start Year
1989
Number of shared co-authors
2
Kikkeri N Naresh
Fred Hutchinson Cancer Research Center
Career Start Year
1989
Number of shared co-authors
5
Suzanne Kamel-Reid
Toronto General Hospital, University Health Network, University of Toronto
Career Start Year
1988
Number of shared co-authors
4
Giorgio Inghirami
Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year
1984
Number of shared co-authors
3
Torsten Haferlach
Taussig Cancer Institute, Cleveland Clinic
Career Start Year
1983
Number of shared co-authors
4
Sherrie L Perkins
University of Utah
Career Start Year
1982
Number of shared co-authors
1
David M Dorfman
Brigham and Women's Hospital and Harvard Medical School
Career Start Year
1982
Number of shared co-authors
1
Elias Campo
Institute for Biomedical Research August Pi I Sunyer
Career Start Year
1981
Number of shared co-authors
3
Mark Raffeld
Center for Cancer Research, National Cancer Institute
Career Start Year
1981
Number of shared co-authors
3
Maryalice Stetler-Stevenson
National Cancer Institute, National Institutes of Health
Career Start Year
1981
Number of shared co-authors
4
row(s) 1 - 30 of 30
Collaborators
Jennifer Dunlap
Oregon Health & Science University
Co-authored papers
18
Richard D Press
Oregon Health and Science University
Co-authored papers
14
Brian J Druker
Oregon Health & Science University
Co-authored papers
7
Stephen E Spurgeon
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers
6
Jeffrey W Tyner
Oregon Health & Science University School of Medicine
Co-authored papers
6
Marc M Loriaux
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers
6
Fei Yang
Oregon Health & Science University
Co-authored papers
5
Richard T Maziarz
Oregon Health & Science University
Co-authored papers
5
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Co-authored papers
5
William H Fleming
Oregon Health & Science University
Co-authored papers
5
Elie Traer
Oregon Health & Science University
Co-authored papers
5
Jessica Leonard
Oregon Health & Science University
Co-authored papers
3
Tauangtham Anekpuritanang
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers
3
Bill H Chang
Oregon Health and Science University
Co-authored papers
3
Devorah C Goldman
Oregon Health & Science University
Co-authored papers
3
Christopher L Corless
Oregon Health & Science University
Co-authored papers
3
Maedeh Mohebnasab
Oregon Health and Science University
Co-authored papers
2
Gail Mandel
Vollum Institute, Oregon Health and Science University
Co-authored papers
2
Weiwei Wang
Xinhua Hospital, Shanghai Jiaotong University of Medicine School
Co-authored papers
2
Christopher A Eide
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers
2
Gabrielle Meyers
Oregon Health and Science University
Co-authored papers
2
Rachel J Cook
Oregon Health and Science University
Co-authored papers
2
Yassmine Akkari
Association for Molecular Pathology
Co-authored papers
2
Huilan Yao
Vollum Institute, Oregon Health & Science University
Co-authored papers
2
Anupriya Agarwal
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers
2
Michael W Deininger
University of Utah Huntsman Cancer Institute
Co-authored papers
2
Daniel N Streblow
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers
2
Cristina E Tognon
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers
2
Ted Laderas
Oregon Health & Science University
Co-authored papers
2
Nicola Long
Oregon Health and Science University
Co-authored papers
2
1 - 30